GlassScriptPhysician profile
Benjamin G Romer
NPI 1699193896
$817.30
in general payments reported to CMS, 2019-2025
12 companies · $673 in 2025
The $673 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111 · 2020: $33.60 · 2025: $673.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $672.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $184.65 | 2025 | Lifevest |
| Cardiva Medical, INC. | $141.95 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Pfizer INC. | $128.68 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $84.84 | 2019-2025 | Eliquis |
| Novartis Pharmaceuticals Corporation | $80.98 | 2025 | |
| Novo Nordisk INC | $44.00 | 2025 | Wegovy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $37.57 | 2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $32.76 | 2019 | |
| Teleflex LLC | $32.24 | 2025 | Guideliner, Vascband |
| Kestra Medical Technology Services, INC. | $19.78 | 2025 | Assure Wcd |
| Ge Healthcare | $18.83 | 2025 | |
| Amgen INC. | $11.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Romer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.